Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001013594-25-001474
Filing Date
2025-11-28
Accepted
2025-11-28 17:38:39
Documents
1
Period of Report
2025-11-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 4120
  Complete submission text file 0001013594-25-001474.txt   6141
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Issuer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 15 EXCHANGE PLACE JERSEY CITY NJ 07302
Business Address 15 EXCHANGE PLACE JERSEY CITY NJ 07302 212-956-2221
PAULSON & CO. INC. (Reporting) CIK: 0001035674 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 251536627